Submitted by dcc on Fri, 2019-06-14 09:17 Study Title: Phase I Double-Blind, Placebo-Controlled Trial of 27 mg Dolcanatide (SP-333) to Demonstrate Colorectal Bioactivity in Healthy VolunteersCIRB: Cancer Prevention and Control CIRBLead Group: CP-CTNet_CLO-Mayo ClinicStatus: CompletedReview Status: Completed
